Why are Cannaflavins and Inflammations Drawing Research Interest?

Different research studies have shown the amazing power of cannaflavins A and B when it comes to dealing with pain and inflammations. In fact, some research has shown that cannaflavins have at least thirty times soothing effect more than aspirin making it an ideal remedy for individuals with extreme pain.


The continuing work of research is helping cement and verify such claims and in the process promote acceptance among a wide spectrum of users. There is increasing attention being given on the medical uses of the Cannabis Sativa as a source of medicinal components enough to address many ailments.


Specifically, there has been attention given to flavonoids found among the 200 or so known active components of the Marijuana plant. Flavonoids are not only found in this wonder plant but can be found in other plants. However, cannaflavonoids are specific to cannabis and have been a major point of study especially for pain management as well as their anti-inflammatory components. These are what referred to as Cannaflavins A and B.

Research backing uses of Cannaflavins

There have been several research studies that are now making us understand why cannaflavins have these strong attributes that make them ideal for remedies to control pain and reduce body inflammations.


In a study published in the August 2019 issue of the journal Phytochemistry, there are clearly more uses of the Sativa plant than the intoxicating and widely misrepresented effects of THC. These include cannaflavins as well as the widely consumed CBD and its byproducts like oil.


However, this research conducted at the Guelph University in Ontario, Canada points that the anti-inflammatory component of cannaflavins are found in low quantity in the cannabis plant and more research needs to be done to produce a molecule that can help in developing a pill for pain or inflammatory remedies.


With modern technology, this discovery offers hope that the little trace of cannaflavins found in Cannabis could be harvested and commercially produced to meet a greater demand. This will also involve both research institutes and universities to have run it through a quality assurance process before being conveyed to pharmaceutical companies and cannabis enterprises.


This, however, might happen in the U.S. as bot cultivation research and production of such anti-inflammatory Cannabidiol is considered illegality. Some states like Massachusetts and Michigan are moving in allowing medical research which is giving an open path to medical use of cannaflavins.

Emulating Canada

Canada lifted the ban on Marijuana after the government was convinced that there were fewer medical concerns with the plant than there were benefits. This has led the adoption and research programs to show the rich components of the plant beyond the recreational purposes.


This has opened up research and production of the various components which in return has attracted massive investments from private sources. Due to this, cannabis enthusiasts are calling on politicians and policymakers to consider allowing some or all components of research in the country.


The partial research component includes looking at other plants that might have higher levels of flavonoids and mixing that in the lab with Cannaflavins to produce rich value for anti-inflammatory aspect.


As research progress, we can only wait and awe at the great potential presented by the cannabis plant and what it offers to the general consumers especially remedying various medical issues.